These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 10234883
1. [Effects of chemical mixtures on embryonic development: examples of experimental models and problems in risk assessment]. Ricciardi C, Macrì C, Maranghi F, Stazi AV, Mantovani A. Ann Ist Super Sanita; 1998; 34(4):519-27. PubMed ID: 10234883 [Abstract] [Full Text] [Related]
2. A new frontier in understanding the mechanisms of developmental abnormalities. Kimmel CA, Generoso WM, Thomas RD, Bakshi KS. Toxicol Appl Pharmacol; 1993 Apr; 119(2):159-65. PubMed ID: 7683149 [Abstract] [Full Text] [Related]
3. Future of toxicology--low-dose toxicology and risk--benefit analysis. Rietjens IM, Alink GM. Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235 [Abstract] [Full Text] [Related]
4. Integrated approaches for the analysis of toxicologic interactions of chemical mixtures. el-Masri HA, Reardon KF, Yang RS. Crit Rev Toxicol; 1997 Mar; 27(2):175-97. PubMed ID: 9099518 [Abstract] [Full Text] [Related]
5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials. Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [Abstract] [Full Text] [Related]
6. [New aspects in the evaluation of risk factors for fetal development]. Mantovani A, Stazi AV, Bernardini G, Broccia ML, Nuccetelli C, Pagano G, Settimi L, Tiboni GM. Ann Ist Super Sanita; 1999 Mar; 35(2):153-63. PubMed ID: 10645648 [Abstract] [Full Text] [Related]
7. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages. Brent RL. Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806 [Abstract] [Full Text] [Related]
8. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Brent RL. Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191 [Abstract] [Full Text] [Related]
9. Significance of excursions of intake above the acceptable daily intake: effect of time and dose in developmental toxicology. Sullivan FM. Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S94-8. PubMed ID: 10597620 [Abstract] [Full Text] [Related]
10. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F, Rohatagi S, Pino M, DeLise B, Zhang J, Nguyen M, Guittin P, Barbellion S, Brunel P, Hofmann T, Schmidt J, Wong M, Lockey P, Lerman S, Clark R. Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [Abstract] [Full Text] [Related]
11. [Assessment of cumulative risk of mixtures with multiple target organs]. Galli CL, Marinovich M. G Ital Med Lav Ergon; 2003 Apr; 25(3):328-9. PubMed ID: 14582250 [Abstract] [Full Text] [Related]
12. Behavioral toxicology in risk assessment: problems and research needs. Mitchell CL, Tilson HA. Crit Rev Toxicol; 1982 Oct; 10(4):265-74. PubMed ID: 6756792 [Abstract] [Full Text] [Related]
13. [Potential role of hormesis in risk assessment in occupational toxicology]. Iavicoli I, Carelli G. G Ital Med Lav Ergon; 2003 Oct; 25 Suppl(3):174-5. PubMed ID: 14979136 [Abstract] [Full Text] [Related]
14. Binary weight-of-evidence evaluations of chemical interactions--15 years of experience. Pohl HR, Mumtaz MM, Scinicariello F, Hansen H. Regul Toxicol Pharmacol; 2009 Aug; 54(3):264-71. PubMed ID: 19445993 [Abstract] [Full Text] [Related]
15. Deciding which chemical mixtures risk assessment methods work best for what mixtures. Teuschler LK. Toxicol Appl Pharmacol; 2007 Sep 01; 223(2):139-47. PubMed ID: 16997340 [Abstract] [Full Text] [Related]
16. Exposure to multiple environmental agents and their effect. Koppe JG, Bartonova A, Bolte G, Bistrup ML, Busby C, Butter M, Dorfman P, Fucic A, Gee D, van den Hazel P, Howard V, Kohlhuber M, Leijs M, Lundqvist C, Moshammer H, Naginiene R, Nicolopoulou-Stamati P, Ronchetti R, Salines G, Schoeters G, ten Tusscher G, Wallis MK, Zuurbier M. Acta Paediatr Suppl; 2006 Oct 01; 95(453):106-13. PubMed ID: 17000577 [Abstract] [Full Text] [Related]
17. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program. Natl Toxicol Program Tech Rep Ser; 2006 Jan 01; (520):4-246. PubMed ID: 16628245 [Abstract] [Full Text] [Related]
18. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A. Reprod Toxicol; 2009 Jul 01; 28(1):1-10. PubMed ID: 19490988 [Abstract] [Full Text] [Related]
19. Experimental and mathematical modeling methods for the investigation of toxicological interactions. El-Masri HA. Toxicol Appl Pharmacol; 2007 Sep 01; 223(2):148-54. PubMed ID: 16996550 [Abstract] [Full Text] [Related]
20. Risk assessment of endocrine disrupters: the role of toxicological studies. Mantovani A. Ann N Y Acad Sci; 2006 Sep 01; 1076():239-52. PubMed ID: 17119206 [Abstract] [Full Text] [Related] Page: [Next] [New Search]